Large investigation, which included more than 500,000 DM patients of whom half was treated with DDp-4 inhibitors, compared the effects of DPP-4 inhibitors with sulfonylurea and revealed no difference in the risk of HF between these two groups [53]. This evidence concerns the gene DPP4 and diabetes mellitus.